IMCC
Price
$2.66
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
16.21M
LIEN
Price
$11.00
Change
+$0.56 (+5.36%)
Updated
Aug 15 closing price
Capitalization
251.02M
81 days until earnings call
Interact to see
Advertisement

IMCC vs LIEN

Header iconIMCC vs LIEN Comparison
Open Charts IMCC vs LIENBanner chart's image
IM Cannabis
Price$2.66
Change-$0.00 (-0.00%)
Volume$17.52K
Capitalization16.21M
Chicago Atlantic BDC
Price$11.00
Change+$0.56 (+5.36%)
Volume$78.11K
Capitalization251.02M
IMCC vs LIEN Comparison Chart in %
Loading...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCC vs. LIEN commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and LIEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (IMCC: $2.66 vs. LIEN: $11.00)
Brand notoriety: IMCC and LIEN are both not notable
IMCC represents the Pharmaceuticals: Generic, while LIEN is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: IMCC: 20% vs. LIEN: 222%
Market capitalization -- IMCC: $16.21M vs. LIEN: $251.02M
IMCC [@Pharmaceuticals: Generic] is valued at $16.21M. LIEN’s [@Investment Managers] market capitalization is $251.02M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $175.76B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B. The average market capitalization across the [@Investment Managers] industry is $7.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 0 FA rating(s) are green whileLIEN’s FA Score has 1 green FA rating(s).

  • IMCC’s FA Score: 0 green, 5 red.
  • LIEN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIEN is a better buy in the long-term than IMCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 3 TA indicator(s) are bullish while LIEN’s TA Score has 4 bullish TA indicator(s).

  • IMCC’s TA Score: 3 bullish, 5 bearish.
  • LIEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LIEN is a better buy in the short-term than IMCC.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а -2.92% price change this week, while LIEN (@Investment Managers) price change was +7.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

The average weekly price growth across all stocks in the @Investment Managers industry was +0.77%. For the same industry, the average monthly price growth was +0.84%, and the average quarterly price growth was +29.70%.

Reported Earning Dates

LIEN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Investment Managers (+0.77% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIEN($251M) has a higher market cap than IMCC($16.2M). IMCC YTD gains are higher at: 14.109 vs. LIEN (-4.113). IMCC has more cash in the bank: 1.39M vs. LIEN (5.4K).
IMCCLIENIMCC / LIEN
Capitalization16.2M251M6%
EBITDA-610KN/A-
Gain YTD14.109-4.113-343%
P/E RatioN/A8.15-
Revenue54.5MN/A-
Total Cash1.39M5.4K25,722%
Total Debt15.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
IMCCLIEN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
64%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
50%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
50%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 4 days ago
50%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 12 days ago
62%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
64%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLIN1.50N/A
N/A
Bridgeline Digital
CRDF2.44N/A
N/A
Cardiff Oncology
SMG62.17-0.33
-0.53%
Scotts Miracle-Gro Company (The)
WTW330.50-4.19
-1.25%
Willis Towers Watson Public Limited
IIIV31.36-0.58
-1.82%
i3 Verticals

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and SCYX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
N/A
SCYX - IMCC
24%
Poorly correlated
+4.78%
TLRY - IMCC
23%
Poorly correlated
-12.71%
CGC - IMCC
22%
Poorly correlated
-12.75%
CRON - IMCC
22%
Poorly correlated
-5.95%
OGI - IMCC
22%
Poorly correlated
-8.33%
More

LIEN and

Correlation & Price change

A.I.dvisor tells us that LIEN and SHPH have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIEN and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
+5.36%
SHPH - LIEN
20%
Poorly correlated
-5.14%
IMCC - LIEN
13%
Poorly correlated
N/A
OXLCP - LIEN
13%
Poorly correlated
+0.16%
NTRSO - LIEN
9%
Poorly correlated
-0.07%
TKNO - LIEN
8%
Poorly correlated
-2.29%
More